Herbal drug for treatment of Gastro-esophageal reflux disease
Phase 2
Completed
- Conditions
- Gastro-oesophageal reflux disease.Gastro-oesophageal reflux disease
- Registration Number
- IRCT2016072129026N1
- Lead Sponsor
- Hormozgan Science & Technology Park
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Written consent and complete knowledge about the study; being diagnosed with Gastro-esophageal reflux disease based on the Montreal definition.
Exclusion Criteria
The participants’ lack of consent to continue their participation in the study; kidney and liver diseases based on laboratory tests; warning symptoms of gastric and esophageal cancers, other chronic digestive diseases and peptic ulcer disease based on patient history, physical examination, laboratory tests and, if necessary, upper endoscopy.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method